Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,685,554 papers from all fields of science
Search
Sign In
Create Free Account
Splenic Marginal Zone B-Cell Lymphoma
Known as:
Marginal Zone Lymphoma of Spleen
, marginal zone splenic lymphoma
, Splenic Marginal Zone Lymphoma
Expand
A B-cell non-Hodgkin lymphoma composed of small lymphocytes which surround and replace the splenic white pulp germinal centers. It involves the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
23 relations
Anemia
Atypical lymphocyte
B lymphoblast
B-Lymphocytes
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
AUF1 is involved in splenic follicular B cell maintenance
Navid Sadri
,
J. Lu
,
M. Badura
,
R. Schneider
BMC Immunology
2010
Corpus ID: 6317560
BackgroundThe adenosine/uridine-rich element (ARE)-binding protein AUF1 functions to regulate the inflammatory response through…
Expand
Highly Cited
2009
Highly Cited
2009
Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer.
S. Sasada
,
M. Ninomiya
,
+7 authors
Norohisa Takakura
Anticancer Research
2009
Corpus ID: 35119622
BACKGROUND The purpose of this study was to investigate the clinicopathological characteristics and frequency of lymph node…
Expand
Highly Cited
2001
Highly Cited
2001
The structure of a major suture zone in the SW Iberian Massif: the Ossa-Morena/Central Iberian contact
J. F. Simancas
,
D. M. Poyatos
,
I. Expósito
,
A. Azor
,
F. Lodeiro
2001
Corpus ID: 129229616
Highly Cited
2000
Highly Cited
2000
Frequency and Characterization of Phenotypic Ig Heavy Chain Allelically Included IgM-Expressing B Cells in Mice1
Vasco M. Barreto
,
A. Cumano
Journal of Immunology
2000
Corpus ID: 11364879
Ig H chain (IgH) allelic exclusion remains a puzzling topic. Here, we address the following question: Do phenotypic IgH…
Expand
Review
1997
Review
1997
Splenic lymphangiomatosis in children.
D. Wadsworth
,
B. Newman
,
S. Abramson
,
B. L. Carpenter
,
R. Lorenzo
Radiology
1997
Corpus ID: 21902851
PURPOSE To study the clinical and imaging features of splenic lymphangiomatosis. MATERIALS AND METHODS The clinical and…
Expand
Highly Cited
1987
Highly Cited
1987
South African red data book--fishes
P. Skelton
1987
Corpus ID: 83272563
Red data sheets are provided for 50 fish species from the continental waters of South Africa and South West Africa/Namibia. The…
Expand
Highly Cited
1985
Highly Cited
1985
Antigen presentation by splenic B cells: resting B cells are ineffective, whereas activated B cells are effective accessory cells for T cell responses.
J. Krieger
,
S. Grammer
,
H. Grey
,
R. Chesnut
Journal of Immunology
1985
Corpus ID: 31615497
In this study, we have investigated the ability of splenic B cells to act as antigen-presenting cells. Previous data had…
Expand
Highly Cited
1981
Highly Cited
1981
Regulation of T cell differentiation: in vitro induction of 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes from athymic mice by a unique lymphokine.
J. Ihle
,
L. Pepersack
,
L. Rebar
Journal of Immunology
1981
Corpus ID: 20592584
The enzyme 20 alpha-hydroxysteroid dehydrogenase (20 alpha SDH) has previously been shown to be a specific enzyme marker of…
Expand
Highly Cited
1979
Highly Cited
1979
CBA/N X-linked B-cell defect prevents NZB B-cell hyperactivity in F1 mice
J. Taurog
,
H. Moutsopoulos
,
Yvonne J. Rosenberg
,
T. Chused
,
Alfred D. Steinberg
Journal of Experimental Medicine
1979
Corpus ID: 9879678
NZB mice and their F1 hybrids produce excessive polyclonal IgM and autoantibodies of both IgM and IgG classes. CBA/N mice and CBA…
Expand
Highly Cited
1949
Highly Cited
1949
The nature of splenic sympathin
W. Peart
Journal of Physiology
1949
Corpus ID: 42508590
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE